'A Potential Huge Benefit For Patients' - PIVOT-006 and the Future of Intermediate-Risk NMIBC

A Watershed Moment In Bladder Cancer Care, According To Leading Oncologists: The IMvigor011 Study & The Rise Of ctDNA-Guided Treatment

Case Western's Dr. Jorge Garcia On Practical Use of ctDNA To Make Better Treatment Decisions For Bladder Cancer Patients

Intravesical Mitomycin Gel: A New Approach For Recurrent NMIBC

Balversa's FDA Approval Means a New, Practice-Changing Option for FGFR-Positive Bladder Cancer

Should Surgery Be Considered for Oligometastatic Bladder Cancer?

New Combination Of Immunotherapy And Chemotherapy Could Effectively Treat Metastatic Bladder Cancer

The Latest Efforts to Preserve the Bladder

Integrating Genetic Testing and PARP Inhibitors in Prostate Cancer Management

Why Don't Checkpoint Inhibitors Work for More Bladder Cancer Patients?

Perioperative EV + Pembrolizumab For MIBC: The New Standard of Care, According to Leading Bladder Cancer Experts

INLEXZO & SunRISe-1: Enthusiasm and Caution From Two Leading Clinicians